Sertraline promotes hippocampus-derived neural stem cells differentiating into neurons but not glia and attenuates LPS-induced cellular damage

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 36, Issue 1, 2012, Pages 183-188

  Peng, Zheng Wu ^a   Xue, Yun Yun ^a   Wang, Hua Ning ^a   Wang, Huai Hai ^a   Xue, Fen ^a   Kuang, Fang ^b   Wang, Bai Ren ^b   Chen, Yun Chun ^a   Zhang, Li Yi ^c   Tan, Qing Rong ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c NONE   (China)

Author keywords

Neural stem cells; Neuronal differentiation; Neuroprotective effect; Sertraline

Indexed keywords

LACTATE DEHYDROGENASE; LIPOPOLYSACCHARIDE; SERTRALINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DAMAGE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GLIA CELL; HIPPOCAMPUS; MALE; NERVE CELL; NERVOUS SYSTEM DEVELOPMENT; NEURAL STEM CELL; NEUROPROTECTION; NONHUMAN; RAT; SEROTONINERGIC NERVE CELL;

EID: 82555172182     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2011.08.014     Document Type: Article

References (46)

1. Bossini L., Tavanti M., Lombardelli A., Calossi S., Polizzotto N.R., Galli R., et al. Changes in hippocampal volume in patients with post-traumatic stress disorder after sertraline treatment. J Clin Psychopharmacol 2007, 27:233-235.
2. Burcusa S.L., Iacono W.G. Risk for recurrence in depression. Clin Psychol Rev 2007, 27:959-985.
3. Cameron H.A., McKay R.D. Adult neurogenesis produces a large pool of new granule cells in the dentate gyrus. J Comp Neurol 2001, 435:406-417.
4. Chen S.J., Kao C.L., Chang Y.L., Yen C.J., Shui J.W., Chien C.S., et al. Antidepressant administration modulates neural stem cell survival and serotoninergic differentiation through bcl-2. Curr Neurovasc Res 2007, 4:19-29.
5. Chen M.C., Hamilton J.P., Gotlib I.H. Decreased hippocampal volume in healthy girls at risk of depression. Arch Gen Psychiatry 2010, 67:270-276.
6. Chiou S.H., Chen S.J., Peng C.H., Chang Y.L., Ku H.H., Hsu W.M., et al. Fluoxetine up-regulates expression of cellular FLICE-inhibitory protein and inhibits LPS-induced apoptosis in hippocampus-derived neural stem cell. Biochem Biophys Res Commun 2006, 343:391-400.
7. Duan W., Peng Q., Masuda N., Ford E., Tryggestad E., Ladenheim B., et al. Sertraline slows disease progression and increases neurogenesis in N171-82Q mouse model of Huntington's disease. Neurobiol Dis 2008, 30:312-322.
8. Encinas J.M., Vaahtokari A., Enikolopov G. Fluoxetine targets early progenitor cells in the adult brain. Proc Natl Acad Sci USA 2006, 103:8233-8238.
9. Fava M., Rosenbaum J.F., Hoog S.L., Tepner R.G., Kopp J.B., Nilsson M.E. Fluoxetine versus sertraline and paroxetine in major depression: tolerability and efficacy in anxious depression. J Affect Disord 2000, 59:119-126.
10. Gayle D.A., Ling Z., Tong C., Landers T., Lipton J.W., Carvey P.M. Lipopolysaccharide (LPS)-induced dopamine cell loss in culture: roles of tumor necrosis factor-alpha, interleukin-1beta, and nitric oxide. Brain Res Dev Brain Res 2002, 133:27-35.
11. Hitoshi S., Alexson T., Tropepe V., Donoviel D., Elia A.J., Nye J.S., et al. Notch pathway molecules are essential for the maintenance, but not the generation, of mammalian neural stem cells. Genes Dev 2002, 16:846-858.
12. Hitoshi S., Maruta N., Higashi M., Kumar A., Kato N., Ikenaka K. Antidepressant drugs reverse the loss of adult neural stem cells following chronic stress. J Neurosci Res 2007, 85:3574-3585.
13. Huang Y.Y., Peng C.H., Yang Y.P., Wu C.C., Hsu W.M., Wang H.J., et al. Desipramine activated Bcl-2 expression and inhibited lipopolysaccharide-induced apoptosis in hippocampus-derived adult neural stem cells. J Pharmacol Sci 2007, 104:61-72.
14. Jin Y., Lim C.M., Kim S.W., Park J.Y., Seo J.S., Han P.L., et al. Fluoxetine attenuates kainic acid-induced neuronal cell death in the mouse hippocampus. Brain Res 2009, 1281:108-116.
15. Klerman G.L., Weissman M.M. The changing epidemiology of depression. Clin Chem 1988, 34:807-812.
16. Kodama M., Fujioka T., Duman R.S. Chronic olanzapine or fluoxetine administration increases cell proliferation in hippocampus and prefrontal cortex of adult rat. Biol Psychiatry 2004, 56:570-580.
17. Kumar P., Kumar A. Possible role of sertraline against 3-nitropropionic acid induced behavioral, oxidative stress and mitochondrial dysfunctions in rat brain. Prog Neuropsychopharmacol Biol Psychiatry 2009, 33:100-108.
18. Lecrubier Y. The burden of depression and anxiety in general medicine. J Clin Psychiatry 2001, 62(Suppl. 8):4-9. [discussion 10-1].
19. Lepine J.P., Caillard V., Bisserbe J.C., Troy S., Hotton J.M., Boyer P. A randomized, placebo-controlled trial of sertraline for prophylactic treatment of highly recurrent major depressive disorder. Am J Psychiatry 2004, 161:836-842.
20. Lesch K.P. Serotonergic gene expression and depression: implications for developing novel antidepressants. J Affect Disord 2001, 62:57-76.
21. Maes M., Bosmans E., Suy E., Vandervorst C., De Jonckheere C., Raus J. Immune disturbances during major depression: upregulated expression of interleukin-2 receptors. Neuropsychobiology 1990, 24:115-120.
22. Maes M., Bosmans E., Suy E., Vandervorst C., DeJonckheere C., Raus J. Depression-related disturbances in mitogen-induced lymphocyte responses and interleukin-1 beta and soluble interleukin-2 receptor production. Acta Psychiatr Scand 1991, 84:379-386.
23. Malberg J.E. Implications of adult hippocampal neurogenesis in antidepressant action. J Psychiatry Neurosci 2004, 29:196-205.
24. Malberg J.E., Blendy J.A. Antidepressant action: to the nucleus and beyond. Trends Pharmacol Sci 2005, 26:631-638.
25. Malberg J.E., Eisch A.J., Nestler E.J., Duman R.S. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci 2000, 20:9104-9110.
26. Manev H., Uz T., Smalheiser N.R., Manev R. Antidepressants alter cell proliferation in the adult brain in vivo and in neural cultures in vitro. Eur J Pharmacol 2001, 411:67-70.
27. Marlatt M.W., Lucassen P.J., van Praag H. Comparison of neurogenic effects of fluoxetine, duloxetine and running in mice. Brain Res 2010, 1341:93-99.
28. Matrisciano F., Bonaccorso S., Ricciardi A., Scaccianoce S., Panaccione I., Wang L., et al. Changes in BDNF serum levels in patients with major depression disorder (MDD) after 6months treatment with sertraline, escitalopram, or venlafaxine. J Psychiatr Res 2009, 43:247-254.
29. McEwen B.S. Stress and hippocampal plasticity. Annu Rev Neurosci 1999, 22:105-122.
30. McKernan D.P., Dinan T.G., Cryan J.F. "Killing the Blues": a role for cellular suicide (apoptosis) in depression and the antidepressant response. Prog Neurobiol 2009, 88:246-263.
31. Mikova O., Yakimova R., Bosmans E., Kenis G., Maes M. Increased serum tumor necrosis factor alpha concentrations in major depression and multiple sclerosis. Eur Neuropsychopharmacol 2001, 11:203-208.
32. Monje M.L., Toda H., Palmer T.D. Inflammatory blockade restores adult hippocampal neurogenesis. Science 2003, 302:1760-1765.
33. O'Brien S.M., Scott L.V., Dinan T.G. Cytokines: abnormalities in major depression and implications for pharmacological treatment. Hum Psychopharmacol 2004, 19:397-403.
34. Pedrazza E.L., Senger M.R., Pedrazza L., Zimmermann F.F., de Freitas Sarkis J.J., Bonan C.D. Sertraline and clomipramine inhibit nucleotide catabolism in rat brain synaptosomes. Toxicol In Vitro 2007, 21:671-676.
35. Peng Q., Masuda N., Jiang M., Li Q., Zhao M., Ross C.A., et al. The antidepressant sertraline improves the phenotype, promotes neurogenesis and increases BDNF levels in the R6/2 Huntington's disease mouse model. Exp Neurol 2008, 210:154-163.
36. Penninx B.W., Kritchevsky S.B., Yaffe K., Newman A.B., Simonsick E.M., Rubin S., et al. Inflammatory markers and depressed mood in older persons: results from the Health, Aging and Body Composition study. Biol Psychiatry 2003, 54:566-572.
37. Santarelli L., Saxe M., Gross C., Surget A., Battaglia F., Dulawa S., et al. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 2003, 301:805-809.
38. Sapolsky R.M. The possibility of neurotoxicity in the hippocampus in major depression: a primer on neuron death. Biol Psychiatry 2000, 48:755-765.
39. Schloss P., Williams D.C. The serotonin transporter: a primary target for antidepressant drugs. J Psychopharmacol 1998, 12:115-121.
40. Schneider L.S., Nelson J.C., Clary C.M., Newhouse P., Krishnan K.R., Shiovitz T., et al. An 8-week multicenter, parallel-group, double-blind, placebo-controlled study of sertraline in elderly outpatients with major depression. Am J Psychiatry 2003, 160:1277-1285.
41. Sheline Y.I., Wang P.W., Gado M.H., Csernansky J.G., Vannier M.W. Hippocampal atrophy in recurrent major depression. Proc Natl Acad Sci USA 1996, 93:3908-3913.
42. Sutcigil L., Oktenli C., Musabak U., Bozkurt A., Cansever A., Uzun O., et al. Pro- and anti-inflammatory cytokine balance in major depression: effect of sertraline therapy. Clin Dev Immunol 2007, 2007:76396.
43. Swenson J.R., O'Connor C.M., Barton D., Van Zyl L.T., Swedberg K., Forman L.M., et al. Influence of depression and effect of treatment with sertraline on quality of life after hospitalization for acute coronary syndrome. Am J Cardiol 2003, 92:1271-1276.
44. Tropepe V., Sibilia M., Ciruna B.G., Rossant J., Wagner E.F., der Kooy D.V. Distinct neural stem cells proliferate in response to EGF and FGF in the developing mouse telencephalon. Dev Biol 1999, 208:166-188.
45. Vaidya V.A., Duman R.S. Depression-emerging insights from neurobiology. Br Med Bull 2001, 57:61-79.
46. Wexler E.M., Geschwind D.H., Palmer T.D. Lithium regulates adult hippocampal progenitor development through canonical Wnt pathway activation. Mol Psychiatry 2008, 13:285-292.